Dergiler / Ulusal Travma ve Acil Cerrahi Dergisi / 2017 / Cilt: 23 - Sayı: 6

Correlation between ischemia-modified albumin and Ranson score in acute pancreatitis

Sayfa
472–476
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Despite important disadvantages, Ranson score still indicates the disease severity more accurately.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:BACKGROUND: Although Ranson score is the most commonly used prognostic model in the severity of acute pancreatitis (AP), ischemia-modified albumin (IMA) has been reported as a novel biomarker of various ischemia-based diseases in recent years.
📊
Temel Bulgular & Veri:The correlation between IMA level and amylase level, Ranson score, and disease severity was evaluated.RESULTS: Twenty-nine (67.4%) patients were diagnosed as mild AP; the remaining 14 (32.6%) patients had moderately severe or severe form of disease, and were classified as severe AP.
💡
Sonuç & Katkı:Despite important disadvantages, Ranson score still indicates the disease severity more accurately.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

BACKGROUND: Although Ranson score is the most commonly used prognostic model in the severity of acute pancreatitis (AP), ischemia-modified albumin (IMA) has been reported as a novel biomarker of various ischemia-based diseases in recent years. The aim of the present study is to investigate the correlation between Ranson score and IMA in patients with AP.METHODS: Forty-three patients with AP were included in the study. All patients were classified as mild and severe AP. Plasma IMA level was measured after diagnosis and before treatment. The correlation between IMA level and amylase level, Ranson score, and disease severity was evaluated.RESULTS: Twenty-nine (67.4%) patients were diagnosed as mild AP; the remaining 14 (32.6%) patients had moderately severe or severe form of disease, and were classified as severe AP. There was no significant difference in the IMA levels between the patient groups (p=0.737). No correlation between IMA levels and amylase levels (p=0.470), Ranson score (p=0.664), and disease severity (p=0.741) was found.CONCLUSION: According to the results from the study, IMA does not seem as a useful marker in earlier prediction of disease severity in AP. Despite important disadvantages, Ranson score still indicates the disease severity more accurately.

🔖

Bu Makaleye Atıf Yap

GULDOGAN, C. E., KILIÇ, M. Ö., BALAMİR, İ., TEZ, M., TURHAN, T. (2017). Correlation between ischemia-modified albumin and Ranson score in acute pancreatitis. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 23 - Sayı: 6, 472–476. https://ajindex.com/articles/323691

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216-20
  2. Gunduz A, Turedi S, Mentese A, Karahan SC, Hos G, Tatli O, et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 2008;26:202-5
  3. Kaya Z, Kayrak M, Gul EE, Altunbaş G, Toker A, Kiyici M, et al. The Role of Ischemia Modified Albumin in Acute Pulmonary Embolism. Heart Views 2014;15:106-10
  4. Bhakthavatsala Reddy C, Cyriac C, Desle HB. Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes. Indian Heart J 2014;66:656
  5. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666-71
  6. Closa D. Free radicals and acute pancreatitis: much ado about. something. Free Radic Res 2013;47:934-40
  7. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. J Emerg Med 2000;19:311-5
  8. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102-11
  9. Maheshwari R, Subramanian RM. Severe Acute Pancreatitis and Necrotizing Pancreatitis. Crit Care Clin 2016;32:279-90
  10. Ranson JH. The timing of biliary surgery in AP. Ann Surg 1979;189:654- 63
  11. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in AP: a large population-based study. Gut 2008;57:1698-703
  12. Leese T, Shaw D. Comparison of three Glasgow multifactor prognostic scoring systems in AP. Br J Surg 1988;75:460-2
  13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29
  14. Lemeshow S, Teres D, Klar J, Avrunin JS, Gehlbach SH, Rapoport J. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993;270:2478-86
  15. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in AP. Gut 1997;41:832-40
  16. Stimac D, Fisic E, Milic S, Bilic-Zulle L, Peric R. Prognostic values of IL-6, IL-8, and IL-10 in AP. J Clin Ga